Pavurutamab Biosimilar – Anti-TNFRSF17;CD3E mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Pavurutamab Biosimilar - Anti-TNFRSF17;CD3E mAb - Research Grade |
|---|---|
| Source | CAS 2250292-39-6 |
| Species | Humanized |
| Expression system | XtenCHO |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3 week if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Applications | ELISA,WB |
| Aliases /Synonyms | Pavurutamab,AMG701, AMG-701, ANTI-BCMA X ANTI-CD3 BITE (BISPECIFIC T CELL ENGAGER) ANTIBODY CONSTRUCT,TNFRSF17;CD3E,anti-TNFRSF17;CD3E |
| Reference | PX-TA1700 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | Bispecific scFv,Kappa;Lambda |
| Clonality | Monoclonal Antibody |
Related products
Antigen
CD269 / TNFRSF17, C-Fc, recombinant protein
PX-P5605
385€
SIL
Stable Istotope Labelled Pavurutamab Biosimilar – Anti-TNFRSF17;CD3E mAb – Research Grade
PX-TA1700-SIL
1500€
Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.